Sanofi sponsors AlphaDetect to boost early detection of Alpha-1 genetic disease.

Sanofi has become an inaugural sponsor of AlphaDetect, a nonprofit focused on improving early detection of Alpha-1 Antitrypsin Deficiency, a genetic lung and liver disease often underdiagnosed. This partnership aims to expand testing and awareness following clinical guidelines to identify patients sooner, improving outcomes. AlphaDetect works with healthcare providers to integrate detection tools and protocols into routine care. Sanofi's support will help scale education and detection efforts, addressing the significant gap where over 90% of affected individuals remain undiagnosed.